Literature DB >> 31595418

Is Testosterone Replacement Therapy in Older Men Effective and Safe?

Andriy Yabluchanskiy1, Panayiotis D Tsitouras2.   

Abstract

The number of older adults over 65 years of age is expected to increase to almost 100 million in the US by 2050, more than double the current figure of 46 million. Advanced age is associated with increased frailty among older Americans and often leads to increased disability, hospitalization, institutionalization, and, eventually, mortality. In search of means to improve age-related risks for adverse health outcomes, the question of restoring diminishing sex hormones has gathered much interest and has led to the practice of sex hormone replacement therapies in older men. Recent data suggest that androgen prescription rates in the US for men older than 60 years of age quadrupled from the years 2001 to 2011. While prescription sales of testosterone have increased from $150 million in 2000 to $1.8 billion in 2011, a significant portion of men prescribed testosterone replacement therapy did not meet the laboratory criteria for hypogonadism. While some clinical trials reported an association between testosterone insufficiency in older men and increased risk of death, the exact effects and consequences of testosterone replacement therapy, specifically in older men, remain unclear. This review is aimed at discussing the possible benefits and complications of testosterone replacement therapy in older men over 60 years of age.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31595418     DOI: 10.1007/s40266-019-00716-2

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  52 in total

1.  Identification of late-onset hypogonadism in middle-aged and elderly men.

Authors:  Frederick C W Wu; Abdelouahid Tajar; Jennifer M Beynon; Stephen R Pye; Alan J Silman; Joseph D Finn; Terence W O'Neill; Gyorgy Bartfai; Felipe F Casanueva; Gianni Forti; Aleksander Giwercman; Thang S Han; Krzysztof Kula; Michael E J Lean; Neil Pendleton; Margus Punab; Steven Boonen; Dirk Vanderschueren; Fernand Labrie; Ilpo T Huhtaniemi
Journal:  N Engl J Med       Date:  2010-06-16       Impact factor: 91.245

Review 2.  Proof of the effect of testosterone on skeletal muscle.

Authors:  S Bhasin; L Woodhouse; T W Storer
Journal:  J Endocrinol       Date:  2001-07       Impact factor: 4.286

3.  Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men.

Authors:  Scott D Moffat; Alan B Zonderman; E Jeffrey Metter; Marc R Blackman; S Mitchell Harman; Susan M Resnick
Journal:  J Clin Endocrinol Metab       Date:  2002-11       Impact factor: 5.958

Review 4.  The effect of testosterone levels on mood in men: a review.

Authors:  Justin M Johnson; Lisa B Nachtigall; Theodore A Stern
Journal:  Psychosomatics       Date:  2013-09-07       Impact factor: 2.386

5.  Testosterone transport in brain: primary role of plasma protein-bound hormone.

Authors:  W M Pardridge; E M Landaw
Journal:  Am J Physiol       Date:  1985-11

Review 6.  Frailty in elderly people.

Authors:  Andrew Clegg; John Young; Steve Iliffe; Marcel Olde Rikkert; Kenneth Rockwood
Journal:  Lancet       Date:  2013-02-08       Impact factor: 79.321

7.  Effects of Testosterone Administration for 3 Years on Subclinical Atherosclerosis Progression in Older Men With Low or Low-Normal Testosterone Levels: A Randomized Clinical Trial.

Authors:  Shehzad Basaria; S Mitchell Harman; Thomas G Travison; Howard Hodis; Panayiotis Tsitouras; Matthew Budoff; Karol M Pencina; Joseph Vita; Connie Dzekov; Norman A Mazer; Andrea D Coviello; Philip E Knapp; Kathleen Hally; Emma Pinjic; Mingzhu Yan; Thomas W Storer; Shalender Bhasin
Journal:  JAMA       Date:  2015-08-11       Impact factor: 56.272

8.  Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy.

Authors:  Prasanth N Surampudi; Christina Wang; Ronald Swerdloff
Journal:  Int J Endocrinol       Date:  2012-03-14       Impact factor: 3.257

9.  Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men.

Authors:  William D Finkle; Sander Greenland; Gregory K Ridgeway; John L Adams; Melissa A Frasco; Michael B Cook; Joseph F Fraumeni; Robert N Hoover
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

10.  Understanding and meeting the needs of the older population: a global challenge.

Authors:  Howard Bergman; Sathya Karunananthan; Luis M G Robledo; Jenny Brodsky; Piu Chan; Maria Cheung; Pascal Bovet
Journal:  Can Geriatr J       Date:  2013-06-03
View more
  2 in total

1.  Toxic masculinity in red blood cell units? Testosterone therapy in blood donors revisited.

Authors:  Kelsey Hazegh; Bradley D Anawalt; Larry J Dumont; Tamir Kanias
Journal:  Transfusion       Date:  2021-09-14       Impact factor: 3.157

2.  The prevalence and demographic determinants of blood donors receiving testosterone replacement therapy at a large USA blood service organization.

Authors:  Kelsey Hazegh; Marjorie D Bravo; Hany Kamel; Larry Dumont; Tamir Kanias
Journal:  Transfusion       Date:  2020-03-16       Impact factor: 3.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.